| Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial F Chollet, J Tardy, JF Albucher, C Thalamas, E Berard, C Lamy, Y Bejot, ... The Lancet Neurology 10 (2), 123-130, 2011 | 1170 | 2011 |
| Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study C Brefel‐Courbon, P Payoux, C Thalamas, F Ory, I Quelven, F Chollet, ... Movement disorders: official journal of the Movement Disorder Society 20 (12 …, 2005 | 454 | 2005 |
| Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans Y Cadroy, JP Bossavy, C Thalamas, L Sagnard, K Sakariassen, B Boneu Circulation 101 (24), 2823-2828, 2000 | 362 | 2000 |
| Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine A Besse-Patin, E Montastier, C Vinel, I Castan-Laurell, K Louche, C Dray, ... International journal of obesity 38 (5), 707-713, 2014 | 332 | 2014 |
| Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study A Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, F Ory-Magne, ... Journal of Neurology, Neurosurgery & Psychiatry 78 (10), 1140-1142, 2007 | 284 | 2007 |
| Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass A Girousse, G Tavernier, C Valle, C Moro, N Mejhert, AL Dinel, ... PLoS biology 11 (2), e1001485, 2013 | 252 | 2013 |
| Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease F Courbon, C Brefel‐Courbon, C Thalamas, MJ Alibelli, I Berry, ... Movement disorders: official journal of the Movement Disorder Society 18 (8 …, 2003 | 250 | 2003 |
| In vivo regulation of human skeletal muscle gene expression by thyroid hormone K Clément, N Viguerie, M Diehn, A Alizadeh, P Barbe, C Thalamas, ... Genome research 12 (2), 281-291, 2002 | 235 | 2002 |
| A genome wide scan for familial high myopia suggests a novel locus on chromosome 7q36 L Naiglin, CH Gazagne, F Dallongeville, C Thalamas, A Idder, O Rascol, ... Journal of medical genetics 39 (2), 118-124, 2002 | 223 | 2002 |
| Atrial natriuretic peptide contributes to the physiological control of lipid mobilization in humans C Moro, F Crampes, C Sengenes, ID Glisezinski, J Galitzky, C Thalamas, ... The FASEB Journal 18 (7), 908-910, 2004 | 216 | 2004 |
| Strenuous but not moderate exercise increases the thrombotic tendency in healthy sedentary male volunteers Y Cadroy, F Pillard, KS Sakariassen, C Thalamas, B Boneu, D Riviere Journal of applied physiology 93 (3), 829-833, 2002 | 216 | 2002 |
| Natriuretic peptides enhance the oxidative capacity of human skeletal muscle S Engeli, AL Birkenfeld, PM Badin, V Bourlier, K Louche, N Viguerie, ... The Journal of clinical investigation 122 (12), 4675-4679, 2012 | 206 | 2012 |
| Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications. L Rostaing, E Chatelut, JL Payen, J Izopet, C Thalamas, H Ton-That, ... Journal of the American Society of Nephrology 9 (12), 2344-2348, 1998 | 203 | 1998 |
| A randomized paired eye comparison of two techniques for treating moderately high myopia: LASIK and artisan phakic lens FJ Malecaze, H Hulin, P Bierer, P Fournié, H Grandjean, C Thalamas, ... Ophthalmology 109 (9), 1622-1630, 2002 | 193 | 2002 |
| Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease O Rascol, I Arnulf, H Peyro‐Saint Paul, C Brefel‐Courbon, M Vidailhet, ... Movement disorders: official journal of the Movement Disorder Society 16 (4 …, 2001 | 181 | 2001 |
| Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease O Rascol, JG Nutt, O Blin, CG Goetz, JM Trugman, C Soubrouillard, ... Archives of neurology 58 (2), 249-254, 2001 | 180 | 2001 |
| Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial F Ory-Magne, JC Corvol, JP Azulay, AM Bonnet, C Brefel-Courbon, ... Neurology 82 (4), 300-307, 2014 | 165 | 2014 |
| ABT‐431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease O Rascol, O Blin, C Thalamas, S Descombes, C Soubrouillard, P Azulay, ... Annals of Neurology: Official Journal of the American Neurological …, 1999 | 146 | 1999 |
| The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men J Galitzky, C Sengenès, C Thalamas, MA Marques, JM Senard, ... Journal of lipid research 42 (4), 536-544, 2001 | 137 | 2001 |
| Triiodothyronine‐mediated upregulation of UCP2 and UCP3 mRNA expression in human skeletal muscle without coordinated induction of mitochondrial respiratory chain genes P Barbe, D Larrouy, C Boulanger, E Chevillotte, N Viguerie, C Thalamas, ... The FASEB Journal 15 (1), 13-15, 2001 | 129 | 2001 |
